Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price dropped 7.4% during trading on Friday . The stock traded as low as $0.14 and last traded at $0.14. Approximately 1,000 shares traded hands during trading, a decline of 73% from the average daily volume of 3,744 shares. The stock had previously closed at $0.15.
Ascletis Pharma Trading Down 7.4 %
The firm has a fifty day moving average of $0.18 and a 200 day moving average of $0.20.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus.
Read More
- Five stocks we like better than Ascletis Pharma
- How to Invest in the Best Canadian Stocks
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- How to Invest in Insurance Companies: A Guide
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
